Mandate

Vinge has advised Lone Star Fund and Stark Group in connection with the sale of the Stark Group to CVC Capital Partners.

Headquartered in Denmark, STARK Group is a leading B2B distributor of heavy building materials for the construction industry in the Nordics and Germany, with a focus on serving professional craftsmen. The business partners with 10,000 suppliers to serve c. 235,000 customers from more than 400 locations in Denmark (incl. Greenland), Sweden, Norway, Finland, and Germany. The transaction is subject to customary conditions and approvals and is expected to close in Q2 2021.

Vinge’s team consisted of, among others, Jonas Bergström, Desirée Sjöblom, Vilhelm Rondahl and Amanda Steen (M&A), Michaela Cronemyr and Isabell Nielsen (Agreements), Frida Ställborn and Kristoffer Larson (Real Estate), Sara Strandberg and Caroline Edwall (Employment), Sofia Bergenstråhle (IP), Ludvig Wettergren and Jolinn Uhlin (Financial Arrangements), Fredrika Hjelmberg (IT), Nicklas Thorgerzon (GDPR), Lina Österberg (Permits), Tove Lövgren Frisk (Compliance) and the VDR assistant Carl Bruneheim.

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025